Navigation Links
ECLIPSE Data on Effects of Otsuka's Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients' Hemodynamics and Urine Output Featured in Heart Failure Society of America's Late Breaking Trials
Date:9/19/2007

out ECLIPSE

ECLIPSE is an international, multicenter, randomized, placebo-controlled single-dose trial conducted at 48 trials sites in United States, Romania and Bulgaria between 2005 and 2006. ECLIPSE investigators enrolled patients with heart failure (New York Heart Association Class III or IV) for at least three months duration due to left ventricular systolic dysfunction and who had a left ventricular ejection fraction (LVEF) of 40 percent or less.

Investigators assessed patients' inclusion criteria for up to two weeks prior to randomization. Suitable candidates underwent insertion of a balloon- floatation pulmonary artery catheter to assess final eligibility criteria. Final doses of cardiac concomitant medications were administered at least two hours prior to catheter insertion. Following catheter insertion, patients entered into a two- to 20-hour stabilization period. Researchers completed hemodynamic assessments periodically during this period to determine final subject eligibility. Potential participants then entered a two-hour baseline period. If a participant met all criteria during the baseline period, he or she was randomly assigned to one of four groups and received a single once- daily oral tablet of placebo or of 15, 30 or 60 milligrams (mg) tolvaptan. Investigators followed participants for up to 24 hours for assessments.

"The ECLIPSE data add` to our existing knowledge about tolvaptan and its prospective uses," said Taro Iwamoto, CEO, COO and President of Otsuka Pharmaceutical Development & Commercialization, Inc. "Tolvaptan, as one of our most advanced candidate therapies, represents the successful application of Otsuka's expertise in the research and development of new medicines."

About Heart Failure

More than 14 million people in Europe(1) and five million U.S. residents(2) have heart failure (HF), a serious chronic condition in which the heart cannot effectively pump blood. The direct and indirect U.S. health care e
'/>"/>

SOURCE Otsuka America Pharmaceutical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
2. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
3. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
4. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
5. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
6. New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate
7. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- RnRMarketResearch.com adds "Visceral Pain - ... of 52 pages with latest updates, data and ... The report "Visceral Pain - Pipeline Review, H1 2015" ... Visceral Pain, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:3/27/2015)... 27, 2015  WebMD Health Corp. (NASDAQ: ... health information, today announced an exclusive White ... Action Plan for Combating Antibiotic-Resistant Bacteria . ... urgency and importance of addressing antibiotic-resistant bacteria ... health.    The WebMD interview, available ...
(Date:3/26/2015)... PASADENA, Calif. , March 26, 2015 ... San Gabriel Valley to perform transcatheter aortic valve replacement ... TAVR procedure is a revolutionary new way to replace ... use of a heart lung machine. The ... heart team led by Azhil ( Alex) Durairaj , ...
Breaking Medicine Technology:Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
... , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... announced today that it,will hold its 2010 Annual Meeting of Shareholders ... Beijing Time. The meeting will be held concurrently at No. 39,Shangdi ... 6 Temple Street, St.,John,s, Antigua . All shareholders of record ...
... The chairman of the U.S. bishops, Committee on Pro-Life Activities ... over its move toward approving a new drug that may induce ... letter to Dr. Margaret Hamburg , Commissioner of the ... criticized the FDA,s move to hold an advisory committee meeting ...
Cached Medicine Technology:Sinovac Schedules 2010 Annual Meeting of Shareholders 2Sinovac Schedules 2010 Annual Meeting of Shareholders 3Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 2Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 3Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 4
(Date:3/28/2015)... AZ. (PRWEB) March 28, 2015 Could ... to a new study by researchers at ... , Produced with the support of the Coffee and ... journal Molecular Psychiatry this past fall, the study—one of ... meta-analysis of genomic data from more than 120,000 regular ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians ... osteoarthritis and musculoskeletal diseases gathered here for the ... first time in the 17-year history of the ... topic is an emerging non-pharmaceutical protocol for enhancing ... of Wolff’s law, osteogenic loading at multiples of ...
(Date:3/28/2015)... 2015 Emergency Medical Care (EMC), a ... Manhattan, recently commemorated its three-year anniversary of being the ... addition to 24-hour urgent care, Emergency Medical Care offers ... this time, Emergency Medical Care’s Urgent Care NYC ... pain, eye injuries, ear infections, fevers, insect bites, burns, ...
(Date:3/28/2015)... 2015 Centurion Service Group will be hosting ... April 2 at their Las Vegas warehouse, located at 4606 ... sale, which consists of equipment from hospitals and surgery centers ... a.m. PDT. , Buyers will find items of all ... are a one-stop-shop,” said Erik Tivin, CEO of Centurion. , ...
(Date:3/28/2015)... March 28, 2015 How best to ... growing field in orthopaedic medicine. While diagnostic hip injections ... confirm the pain etiology, research presented today at the ... Specialty Day suggests that pain relief from this diagnostic ... surgery. , “Our study looked to assess if ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
... Speaker Nancy Pelosi,spoke at the Congressional Gold Medal ceremony ... Dr. Michael DeBakey. Below are the,Speaker,s remarks:, "Good ... President Bush,leaders of the House and Senate to honor ... and my colleague Representative Al,Green, and others who worked ...
... CHAPEL HILL, N.C., April 23 Global leaders ... as a powerful tool for competing in today,s ... firm Best Practices, LLC.,The study further reveals -- ... strategic process of transforming raw competitive data,into actionable ...
... Glaser Pediatric AIDS Foundation (EGPAF), a world leader in ... award five grants totaling $1 million to researchers to ... , Shan Lu, MD, PhD, professor of medicine at ... Katherine Ruiz De Luzuriaga, MD, professor of pediatrics and ...
... New Study, FALLS CHURCH, Va. and CUMMAQUID, ... in close,association with research analysis partner Cambashi Ltd, ... new survey on current industry,challenges and practices. The ... information systems and applications, and,performance., The research ...
... inflammation, hints of new treatments for disease , , WEDNESDAY, ... have discovered how tumors develop in the stomach, a ... cancer. , In a study done on mice, scientists ... for Cancer Research (LICR) found that blocking the signaling ...
... WINSTON-SALEM, N.C., April 23 Reynolds,American Inc. (NYSE: ... of first-quarter 2008 financial results on Wednesday, April 30,2008. ... During the call, members of the Reynolds American ... conference call will be available online on a listen-only ...
Cached Medicine News:Health News:Pelosi: 'By Literally Fixing Broken Hearts, Dr. DeBakey Has Given Hope and Health to Millions' 2Health News:Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines 2Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 2Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 3Health News:Risk Management: Best Practices for Medical Device Profitability 2Health News:Scientists Discover How Stomach Tumors Form 2Health News:RAI to Webcast First Quarter 2008 Earnings Conference Call 2
... Kendall provides hospitals and alternate care ... tracheostomy care trays which offer the ... control. Designed with the guidance of ... trays provide exactly what is required ...
... Each KIMBERLY-CLARK BALLARD Component ... T-Pieces, Elbows and Double ... configurations. Customer-oriented presentation to ... sterilized. Also available in ...
... permanent flexible tube extension on ... neck flange helps keep connections ... and stoma, enhancing patient mobility ... FlexTend™ tracheostomy tubes improve tube ...
... permanent flexible tube extension on ... neck flange helps keep connections ... and stoma, enhancing patient mobility ... FlexTend™ tracheostomy tubes improve tube ...
Medicine Products: